Dr Wolfgang Rehmann
Wolfgang Rehmann counts among Germany’s acknowledged experts in the field of pharmaceutical and medical law.
His clients include medium-sized and international enterprises engaged in the manufacture and distribution of pharmaceutical, medicinal or medical-technological products, as well as companies acting as consultants in that area.
Wolfgang Rehmann offers both advice and forensic services to leading companies of the Life Sciences industry. His forensic work is presented before German courts and also the EU courts in Luxembourg, concentrating on issues of pharmaceutical law, intellectual property, antitrust law and Community law.
Wolfgang Rehmann passed the first and second legal state exams in 1979 and 1982, respectively, while at the same time earning his doctor’s degree in banking law. A member of the law firm since 1983, he became a partner in 1987. Wolfgang Rehmann is the Managing Partner of Taylor Wessing Germany.
Wolfgang Rehmann regularly publishes specialist articles and is the author of the Kommentar zum Arzneimittelrecht published by Beck, as well as co-author of the Kommentar zum Medizinprodukterecht, also by Beck. He is a member of the Deutsche Vereinigung für gewerblichen Rechtsschutz (GRUR) and the International League of Competition Law.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
Insolvency proceedings were opened in respect of the assets of a German resident; the liquidator then sought to set aside a transaction that had been entered into with a resident of Switzerland.
As of 1 October 2012, transfers of majority shares in a private limited liability company in Slovakia have become more complicated.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town